Gilead Sciences (GILD), Arcus Biosciences (RCUS) Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/8/2026

1. SPCX
2. CRNX
3. USO
4. VRTX
5. SPY
6. RIVN
7. NVDA
8. LMT
9. WMT
10. CMPS

Go back to Gilead Sciences (GILD), Arcus Biosciences (RCUS) Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies

Arcus Biosciences (RCUS) Prices 11M Share Common Offering at $27.50/Sh

May 29, 2020 5:53 AM EDT

Arcus Biosciences, Inc. (NYSE: RCUS) today announced the pricing of an underwritten public offering of 11,000,000 shares of its common stock at a price to the public of $27.50 per share. Gross proceeds to Arcus Biosciences from the offering are expected to be $302.5 million, before deducting... More